Skip to main content
OpenTrials

Clinical trial condition

Lipid Metabolism Disorders

Explore clinical trials studying Lipid Metabolism Disorders. Study availability and eligibility vary by location and protocol.

3,307 public trials 330 recruiting studies
Refine in advanced search Browse all conditions

Lipid Metabolism Disorders trial results

Active, Not Recruiting

A Study to Evaluate the Effect of Venglustat Tablets on Left Ventricular Mass Index in Male and Female Adult Participants With Fabry Disease

NCT05280548

Conditions
Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +19 more
Locations
  • University of Alabama -The Kirklin Clinic- Site Number : 8400010 Birmingham, Alabama, United States
  • University of California Los Angeles Medical Center- Site Number : 8400008 Los Angeles, California, United States
  • Emory University School of Medicine - Atlanta- Site Number : 8400009 Atlanta, Georgia, United States
  • Ann & Robert H. Lurie Children's Hospital of Chicago- Site Number : 8400005 Chicago, Illinois, United States
View all 54 locations
View Trial Details
Active, Not Recruiting

A Study of DII235 in Adults With Elevated Lipoprotein(a)

NCT07235046

Conditions
Arterial Occlusive Diseases, Arteriosclerosis, Atherosclerosis, +8 more
Locations
  • Parkway Medical Center Birmingham, Alabama, United States
  • Heart Center Research Llc Huntsville, Alabama, United States
  • Cardiology and Medicine Clinic PA Little Rock, Arkansas, United States
  • National Heart Institute Beverly Hills, California, United States
View all 63 locations
View Trial Details
Active, Not Recruiting

A Study to Investigate the Effect of AZD0780 Tablets in Combination With Rosuvastatin Tablets on Low Density Lipoprotein Cholesterol Levels (LDL-C) in Adult Participants With Dyslipidaemia

NCT07218900

Conditions
Dyslipidaemia, Dyslipidemias, Lipid Metabolism Disorders, +2 more
Locations
  • Research Site Aramil, Russia
  • Research Site Ivanovo, Russia
  • Research Site Moscow, Russia
  • Research Site Moscow, Russia
View Trial Details
Active, Not Recruiting

A Phase 3 Study to Evaluate Safety and Biomarkers of Resmetirom (MGL-3196) in Patients With Non-alcoholic Fatty Liver Disease (NAFLD), MAESTRO-NAFLD-Open-Label-Extension (MAESTRO-NAFLD-OLE)

NCT04951219

Conditions
Digestive System Diseases, Dyslipidemias, Endocrine System Diseases, +14 more
Locations
  • Central Research Associates Birmingham, Alabama, United States
  • Arizona Liver Health - Chandler Chandler, Arizona, United States
  • East Valley Family Physicians Chandler, Arizona, United States
  • The Institute For Liver Health - Glendale Glendale, Arizona, United States
View all 76 locations
View Trial Details
Active, Not Recruiting

Study of MAR001 in Adults With Elevated Triglycerides and Remnant Cholesterol

NCT07028749

Conditions
Dyslipidemias, Hyperlipidemias, Hypertriglyceridemia, +3 more
Locations
  • Marea Site 328 Anniston, Alabama, United States
  • Marea Site 329 Mobile, Alabama, United States
  • Marea Site 313 Little Rock, Arkansas, United States
  • Marea Site 306 Hamden, Connecticut, United States
View all 54 locations
View Trial Details

Related conditions